InfuSystem Holdings has an opportunity in the oncology market that it can exploit to sustain its growth and profitability.
Incyte (NASDAQ: INCY) and Enable Injections have formed a strategic partnership to co-develop and commercialize targeted cancer therapies using Enable’s enFuse® On-Body Delivery System, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback